Cite
HARVARD Citation
Portman, N. et al. (2019). Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer. Endocrine-related cancer. 26 (1), pp. R15-R30. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Portman, N. et al. (2019). Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer. Endocrine-related cancer. 26 (1), pp. R15-R30. [Online].